He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
The facility will manufacture tablets, capsules, and injections for the oncology segment
Operations of Line II was stopped due to a fire incident earlier
Subscribe To Our Newsletter & Stay Updated
